25I-NBOMe: Difference between revisions

Line 6:

| ''[[25I-NBOMe/Summary|Summary sheet: 25I-NBOMe]]''

|}

'''25I-NBOMe''' ('''2C-I-NBOMe''') is a derivative of the [[Chemical class::Phenethylamine|substituted phenethylamine]] [[Psychoactive class::psychedelic]] [[2C-I]], discovered in 2003 by Ralf Heim at the Free University of Berlin,<ref name="Ralf Heim PhD. (2010-02-28)">Ralf Heim PhD. (2010-02-28) "Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur. Entwicklung eines neuen Struktur-Wirkungskonzepts." | http://www.diss.fu-berlin.de/diss/receive/FUDISS_thesis_000000001221 (in German). diss.fu-berlin.de. Retrieved 2013-05-10.</ref> and subsequently investigated by a team at Purdue University led by [[David E. Nichols|David Nichols]].<ref name="Michael Robert Braden PhD. (2007)">Michael Robert Braden PhD. (2007). "Towards a biophysical understanding of hallucinogen action." | http://proquest.umi.com/pqdlink?Ver=1&Exp=01-23-2014&FMT=7&DID=1417800971&RQT=309&attempt=1&cfc=1 Purdue University. Retrieved 2012-08-08.</ref>

'''25I-NBOMe''' (also known as '''2C-I-NBOMe''', '''Cimbi-5''' or '''N-Bomb''' (although this term might also include other members of the [[25x-NBOMe]] family)) is a derivative of the [[Chemical class::Phenethylamine|substituted phenethylamine]] [[Psychoactive class::psychedelic]] [[2C-I]], discovered in 2003 by Ralf Heim at the Free University of Berlin,<ref name="Ralf Heim PhD. (2010-02-28)">Ralf Heim PhD. (2010-02-28) "Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur. Entwicklung eines neuen Struktur-Wirkungskonzepts." | http://www.diss.fu-berlin.de/diss/receive/FUDISS_thesis_000000001221 (in German). diss.fu-berlin.de. Retrieved 2013-05-10.</ref> and subsequently investigated by a team at Purdue University led by [[David E. Nichols|David Nichols]].<ref name="Michael Robert Braden PhD. (2007)">Michael Robert Braden PhD. (2007). "Towards a biophysical understanding of hallucinogen action." | http://proquest.umi.com/pqdlink?Ver=1&Exp=01-23-2014&FMT=7&DID=1417800971&RQT=309&attempt=1&cfc=1 Purdue University. Retrieved 2012-08-08.</ref>

It is worth noting that compounds of the [[25x-NBOMe|NBOMe]] class are not [[oral]]ly active and should, therefore, be taken [[sublingual]]ly by simply placing the substance into one's mouth and allowing it to absorb over a period of 30 minutes slowly.

@@ Line 6: / Line 6: @@
 | ''[[25I-NBOMe/Summary|Summary sheet: 25I-NBOMe]]''
 |}
-'''25I-NBOMe''' ('''2C-I-NBOMe''') is a derivative of the [[Chemical class::Phenethylamine|substituted phenethylamine]] [[Psychoactive class::psychedelic]] [[2C-I]], discovered in 2003 by Ralf Heim at the Free University of Berlin,<ref name="Ralf Heim PhD. (2010-02-28)">Ralf Heim PhD. (2010-02-28) "Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur. Entwicklung eines neuen Struktur-Wirkungskonzepts." | http://www.diss.fu-berlin.de/diss/receive/FUDISS_thesis_000000001221 (in German). diss.fu-berlin.de. Retrieved 2013-05-10.</ref> and subsequently investigated by a team at Purdue University led by [[David E. Nichols|David Nichols]].<ref name="Michael Robert Braden PhD. (2007)">Michael Robert Braden PhD. (2007). "Towards a biophysical understanding of hallucinogen action." | http://proquest.umi.com/pqdlink?Ver=1&Exp=01-23-2014&FMT=7&DID=1417800971&RQT=309&attempt=1&cfc=1 Purdue University. Retrieved 2012-08-08.</ref>
+'''25I-NBOMe''' (also known as '''2C-I-NBOMe''', '''Cimbi-5''' or '''N-Bomb''' (although this term might also include other members of the [[25x-NBOMe]] family)) is a derivative of the [[Chemical class::Phenethylamine|substituted phenethylamine]] [[Psychoactive class::psychedelic]] [[2C-I]], discovered in 2003 by Ralf Heim at the Free University of Berlin,<ref name="Ralf Heim PhD. (2010-02-28)">Ralf Heim PhD. (2010-02-28) "Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur. Entwicklung eines neuen Struktur-Wirkungskonzepts." | http://www.diss.fu-berlin.de/diss/receive/FUDISS_thesis_000000001221 (in German). diss.fu-berlin.de. Retrieved 2013-05-10.</ref> and subsequently investigated by a team at Purdue University led by [[David E. Nichols|David Nichols]].<ref name="Michael Robert Braden PhD. (2007)">Michael Robert Braden PhD. (2007). "Towards a biophysical understanding of hallucinogen action." | http://proquest.umi.com/pqdlink?Ver=1&Exp=01-23-2014&FMT=7&DID=1417800971&RQT=309&attempt=1&cfc=1 Purdue University. Retrieved 2012-08-08.</ref>
 It is worth noting that compounds of the [[25x-NBOMe|NBOMe]] class are not [[oral]]ly active and should, therefore, be taken [[sublingual]]ly by simply placing the substance into one's mouth and allowing it to absorb over a period of 30 minutes slowly.